Literature DB >> 12236792

Functionalized congeners of tyrosine-based P2X(7) receptor antagonists: probing multiple sites for linking and dimerization.

Wangzhong Chen1, R Gnana Ravi, Sylvia B Kertesy, George R Dubyak, Kenneth A Jacobson.   

Abstract

Chemically funtionalized analogues of antagonists of the P2X(7) receptor, an ATP-gated cation channel, were synthesized as tools for biophysical studies of the receptor. These functionalized congeners were intended for use in chemical conjugation with retention of biological potency. The antagonists were L-tyrosine derivatives, related to [N-benzyloxycarbonyl-O-(4-arylsulfonyl)-L-tyrosyl]benzoylpiperazine (such as MRS2409, 2). The analogues were demonstrated to be antagonists in an assay of human P2X(7) receptor function, consisting of inhibition of ATP-induced K(+) efflux in HEK293 cells expressing the recombinant receptor. The analogues were of the general structure R(1)-Tyr(OR(2))-piperazinyl-R(3), in which three positions (R(1)-R(3)) were systematically varied in structure through introduction of chemically reactive groups. Each of the three positions was designed to incorporate a 3- or 4-nitrophenyl group. The nitro groups were reduced using NaBH(4)-copper(II) acetylacetonate to amines, which were either converted to the isothiocyanate groups, as potential affinity labels for the receptor, or acylated, as models for conjugation. An alternate route to N(alpha)-3-aminobenzyloxycarbonyl functionalization was devised. The various positions of functionalization were compared for effects on biological potency, and the R(2) and R(3) positions were found to be most amenable to derivatization with retention of high potency. Four dimeric permutations of the antagonists were synthesized by coupling each of the isothiocyanate derivatives to either the precursor amine or to other amine congeners. Only dimers linked at the R(2)-position were potent antagonists. In concentration-response studies, two derivatives, a 3-nitrobenzyloxycarbonyl derivative 18 and a 4-nitrotoluenesulfonate 26b, displayed IC(50) values of roughly 100 nM as antagonists of P2X(7) receptor-mediated K(+) flux.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12236792      PMCID: PMC5577561          DOI: 10.1021/bc020025i

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  30 in total

Review 1.  Salivary gland P2 nucleotide receptors.

Authors:  J T Turner; L A Landon; S J Gibbons; B R Talamo
Journal:  Crit Rev Oral Biol Med       Date:  1999

2.  P2X7/P2Z purinoreceptor-mediated activation of transcription factor NFAT in microglial cells.

Authors:  D Ferrari; C Stroh; K Schulze-Osthoff
Journal:  J Biol Chem       Date:  1999-05-07       Impact factor: 5.157

3.  Hetero-oligomeric assembly of P2X receptor subunits. Specificities exist with regard to possible partners.

Authors:  G E Torres; T M Egan; M M Voigt
Journal:  J Biol Chem       Date:  1999-03-05       Impact factor: 5.157

4.  Functional evidence of distinct ATP activation sites at the human P2X(7) receptor.

Authors:  M Klapperstück; C Büttner; G Schmalzing; F Markwardt
Journal:  J Physiol       Date:  2001-07-01       Impact factor: 5.182

5.  Towards a revised nomenclature for P1 and P2 receptors.

Authors:  B B Fredholm; M P Abbracchio; G Burnstock; G R Dubyak; T K Harden; K A Jacobson; U Schwabe; M Williams
Journal:  Trends Pharmacol Sci       Date:  1997-03       Impact factor: 14.819

6.  Purification and Recognition of Recombinant Mouse P2X(1) Receptors Expressed in a Baculovirus System.

Authors:  Liping Chen; James P Hardwick; Peter McPhie; Michail V Sitkovsky; Kenneth A Jacobson
Journal:  Drug Dev Res       Date:  2000-10-16       Impact factor: 4.360

7.  P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels.

Authors:  A Nicke; H G Bäumert; J Rettinger; A Eichele; G Lambrecht; E Mutschler; G Schmalzing
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

8.  Potent P2X7 Receptor Antagonists: Tyrosyl Derivatives Synthesized Using a Sequential Parallel Synthetic Approach.

Authors:  R Gnana Ravi; Sylvia B Kertesy; George R Dubyak; Kenneth A Jacobson
Journal:  Drug Dev Res       Date:  2001-12-14       Impact factor: 4.360

9.  Covalent modification of transmembrane span III of the A1 adenosine receptor with an antagonist photoaffinity probe.

Authors:  A P Kennedy; K C Mangum; J Linden; J N Wells
Journal:  Mol Pharmacol       Date:  1996-10       Impact factor: 4.436

10.  Tissue distribution of the P2X7 receptor.

Authors:  G Collo; S Neidhart; E Kawashima; M Kosco-Vilbois; R A North; G Buell
Journal:  Neuropharmacology       Date:  1997-09       Impact factor: 5.250

View more
  6 in total

Review 1.  Molecular recognition at purine and pyrimidine nucleotide (P2) receptors.

Authors:  Kenneth A Jacobson; Stefano Costanzi; Michihiro Ohno; Bhalchandra V Joshi; Pedro Besada; Bin Xu; Susanna Tchilibon
Journal:  Curr Top Med Chem       Date:  2004       Impact factor: 3.295

Review 2.  Mechanisms for inhibition of P2 receptors signaling in neural cells.

Authors:  Fernando A González; Gary A Weisman; Laurie Erb; Cheikh I Seye; Grace Y Sun; Betty Velázquez; Melvin Hernández-Pérez; Nataliya E Chorna
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

Review 3.  Agonists and antagonists for P2 receptors.

Authors:  Kenneth A Jacobson; Stefano Costanzi; Bhalchandra V Joshi; Pedro Besada; Dae Hong Shin; Hyojin Ko; Andrei A Ivanov; Liaman Mamedova
Journal:  Novartis Found Symp       Date:  2006

4.  Synthesis and structure-activity relationship studies of tyrosine-based antagonists at the human P2X7 receptor.

Authors:  Ga Eun Lee; Bhalchandra V Joshi; Wangzhong Chen; Lak Shin Jeong; Hyung Ryong Moon; Kenneth A Jacobson; Yong-Chul Kim
Journal:  Bioorg Med Chem Lett       Date:  2007-11-28       Impact factor: 2.823

Review 5.  Functionalized congener approach to the design of ligands for G protein-coupled receptors (GPCRs).

Authors:  Kenneth A Jacobson
Journal:  Bioconjug Chem       Date:  2009-04-30       Impact factor: 4.774

6.  Chelerythrine and other benzophenanthridine alkaloids block the human P2X7 receptor.

Authors:  Anne N Shemon; Ronald Sluyter; Arthur D Conigrave; James S Wiley
Journal:  Br J Pharmacol       Date:  2004-06-21       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.